The DOI matches its Crossref record; 265 of the 265 references it cites were found in a registry or an index.
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo
Open accessAbstract
Adoptive T-cell therapy with gene-modified T cells expressing a tumor-reactive T-cell receptor or chimeric antigen receptor (CAR) is a rapidly growing field of translational medicine and has shown success in the treatment of B-cell malignancies and solid tumors. In all reported trials, patients have received T-cell products comprising random compositions of CD4+ and CD8+ naive and memory T cells, meaning that each patient received a different therapeutic agent. This variation may have influenced the efficacy of T-cell therapy, and complicates comparison of outcomes between different patients and across trials. We analyzed CD19 CAR-expressing effector T cells derived from different subsets (CD4+/CD8+ naive, central memory, effector memory). T cells derived from each of the subsets were efficiently transduced and expanded, but showed clear differences in effector function and proliferation in vitro and in vivo. Combining the most potent CD4+ and CD8+ CAR-expressing subsets, resulted in synergistic antitumor effects in vivo. We show that CAR-T-cell products generated from defined T-cell subsets can provide uniform potency compared with products derived from unselected T cells that vary in phenotypic composition. These findings have important implications for the formulation of T-cell products for adoptive therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–265 of 265
Graham, D. L., Hoppenot, R. G., Hendryx, A., & Self, D. W. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0473-5 · Cited by 84
Kilts, J. D., Connery, H. S., Arrington, E. G., Lewis, M. M., Lawler, C. P., Oxford, G. S., O’Malley, K. L., Todd, R. D., Blake, B. L., Nichols, D. E., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1179 · Cited by 83
Carbonell, C. S., Rueda‐Orozco, P. E., Gómez, E. S., Buzsáki, G., Marsicano, G., & Robbe, D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217144110 · Cited by 80
Effects of the full dopamine D1 receptor agonist dihydrexidine in Parkinson's disease.
Blanchet, P. J., Fang, J., Gillespie, M., Sabounjian, L., Locke, K. W., Gammans, R. E., Mouradian, M. M., & Chase, T. N. (1998) · PubMed · Cited by 79
Subnormal retinal oxygenation response precedes diabetic-like retinopathy.
Berkowitz, B. A., Kowluru, R. A., Frank, R. N., et al. (1999) · PubMed · Cited by 78
Mitropoulou, V., Harvey, P. D., Maldari, L. A., Moriarty, P. J., New, A. S., Silverman, J. M., & Siever, L. J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01426-9 · Cited by 78
Skosnik, P. D., Krishnan, G. P., Aydt, E. E., Kuhlenshmidt, H. A., & O’Donnell, B. F. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.10.1798 · Cited by 78
Schneider, J. S., Sun, Z., & Roeltgen, D. P. (1994) · Brain Research · doi:10.1016/0006-8993(94)90471-5 · Cited by 75
de Martin, R., Mrowietz, U., Wiegrebe, W., Jirovský, D., Loewe, R. P., Pillinger, M., Gröger, M., Holnthoner, W., Wolff, K., & Petzelbauer, P. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01576.x · Cited by 74
Oxygen consumption and distribution in the Long-Evans rat retina
Lau, J. C., & Linsenmeier, R. A. (2012) · Experimental Eye Research · doi:10.1016/j.exer.2012.07.004 · Cited by 74
Rubant, S., Ludwig, R. J., Diehl, S., Hardt, K., Kaufmann, R., Pfeilschifter, J. M., & Boehncke, W. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700996 · Cited by 70
McClure, M. M., Harvey, P. D., Goodman, M. S., Triebwasser, J., New, A. S., Koenigsberg, H. W., Sprung, L., Flory, J. D., & Siever, L. J. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.5 · Cited by 68
Novel Serial Positive Enrichment Technology Enables Clinical Multiparameter Cell Sorting
Stemberger, C., Dreher, S., Tschulik, C., Piossek, C., Bet, J., Yamamoto, T. N., Schiemann, M., Neuenhahn, M., Martin, K., Schlapschy, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035798 · Cited by 68
Self-citationGesser, B., Johansen, C., Rasmussen, M. K., Funding, A. T., Otkjær, K., Kjellerup, R. B., Kragballe, K., & Iversen, L. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700859 · Cited by 67
Effects of Monomethylfumarate on Human Granulocytes
Nibbering, P. H., Thio, B., Zomerdijk, T. P. L., Bezemer, A. C., Beijersbergen, R. L., & van Furth, R. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12358715 · Cited by 67
Ali, A. B., & Todorova, M. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07165.x · Cited by 66
Physicians and Medical Marijuana
Kleber, H. D., & DuPont, R. L. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12030373 · Cited by 65
Mottola, D. M., Laiter, S., Watts, V. J., Tropsha, A., Wyrick, S. D., Nichols, D. E., & Mailman, R. B. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9502100 · Cited by 64
McClure, M. M., Barch, D. M., Flory, J. D., Harvey, P. D., & Siever, L. J. (2008) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.117.2.342 · Cited by 63
Role of FcRs in Animal Model of Autoimmune Bullous Pemphigoid
Zhao, M., Trimbeger, M. E., Li, N., Diaz, L. A., Shapiro, S. D., & Liu, Z. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3398 · Cited by 63
Parkinson's disease and D1 dopamine receptors.
Mailman, R. B., Huang, X., & Nichols, D. E. (2001) · PubMed · Cited by 63
Isoflurane-Induced Vasodilation: Role of the ??-Adrenergic Nervous System
Schwinn, D. A., McIntyre, R. W., & Reves, J. G. (1990) · Anesthesia & Analgesia · doi:10.1213/00000539-199011000-00001 · Cited by 62
Probing cortical dopamine function in schizophrenia: what can D1 receptors tell us?
Abi‐Dargham, A. (2003) · Europe PMC (PubMed Central) · Cited by 62
Watts, V. J., Lawler, C. P., Gilmore, J. H., Southerland, S. B., Nichols, D. E., & Mailman, R. B. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90076-t · Cited by 61
Spice: A Legal Marijuana Equivalent
Johnson, L. A., Johnson, R. L., & Alfonzo, C. (2011) · Military Medicine · doi:10.7205/milmed-d-10-00356 · Cited by 60
Giardina, W. J., & Williams, M. J. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00201.x · Cited by 60
The Effect of Chronic Cannabinoids on Broadband EEG Neural Oscillations in Humans
Skosnik, P. D., D’Souza, D. C., Steinmetz, A. B., Edwards, C. R., Vollmer, J. M., Hetrick, W. P., & O’Donnell, B. F. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.65 · Cited by 60
Egan, M. F., Zhao, X., Gottwald, R., Mozley, L. H., Zhang, Y., Snavely, D. B., Lines, C., & Michelson, D. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.02.030 · Cited by 58
Spare receptors and intrinsic activity: Studies with D1 dopamine receptor agonists
Watts, V. J., Lawler, C. P., Gonzales, A. J., Zhou, Q., Civelli, O., Nichols, D. E., & Mailman, R. B. (1995) · Synapse · doi:10.1002/syn.890210211 · Cited by 57
Kirrane, R., Mitropoulou, V., Nunn, M., New, A. S., Harvey, P. D., Schopick, F., Silverman, J., & Siever, L. J. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00075-5 · Cited by 55
Hammers, C. M., Bieber, K., Kalies, K., Banczyk, D., Ellebrecht, C. T., Ibrahim, S. M., Zillikens, D., Ludwig, R. J., & Westermann, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100796 · Cited by 55
Regulation of retinal oxygen metabolism in humans during graded hypoxia
Palkovits, S., Told, R., Schmidl, D., Boltz, A., Napora, K. J., Lasta, M., Kaya, S., Werkmeister, R. M., Popa‐Cherecheanu, A., Garhöfer, G., et al. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00479.2014 · Cited by 54
Wallbrecht, K., Drick, N., Hund, A., & Schön, M. P. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01376.x · Cited by 53
Yu, X., Holdorf, K., Kasper, B., Zillikens, D., Ludwig, R. J., & Petersen, F. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.230 · Cited by 52
Siegel, B. V., Trestman, R. L., O'Flaithbheartaigh, S., Mitropoulou, V., D, F. A. M., Kirrane, R., Silverman, J. M., Schmeidler, J., Keefe, R. S. E., & Siever, L. J. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00002-x · Cited by 52
Schön, M. P., & Ludwig, R. J. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.2.225 · Cited by 51
D1 Agonist Dihydrexidine Releases Acetylcholine and Improves Cognitive Performance in Rats
Steele, T., Hodges, D. B., Levesque, T. R., & Locke, K. W. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00290-6 · Cited by 50
Emerging treatments for pemphigoid diseases
Ludwig, R. J., Kalies, K., Köhl, J., Zillikens, D., & Schmidt, E. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.06.003 · Cited by 49
Converging evidence for gamma synchrony deficits in schizophrenia
Roach, B. J., Ford, J. M., Hoffman, R. E., & Mathalon, D. H. (2013) · Supplements to Clinical neurophysiology · doi:10.1016/b978-0-7020-5307-8.00011-9 · Cited by 48
Dihydrexidine — The First Full Dopamine D1Receptor Agonist
Salmi, P., Isacson, R., & Kull, B. (2004) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2004.tb00024.x · Cited by 48
Stevens, P. R., & Hong, D. (1984) · Microchemical Journal · doi:10.1016/0026-265x(84)90034-1 · Cited by 48
Hellberg, L., Samavedam, U. K. S. R. L., Holdorf, K., Hänsel, M., Recke, A., Beckmann, T., Steinhorst, K., Boehncke, W., Kirchner, T., Möckel, N., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.91 · Cited by 48
Darney, K. J., Lewis, M., Brewster, W. K., Nichols, D. E., & Mailman, R. B. (1991) · PubMed · Cited by 47
Holderith, N. B., Németh, B., Papp, O. I., Veres, J. M., Nagy, G. A., & Hájos, N. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.216259 · Cited by 42
Differential roles for β2 integrins in experimental autoimmune bullous pemphigoid
Liu, Z., Zhao, M., Li, N., Diaz, L. A., & Mayadas, T. N. (2005) · Blood · doi:10.1182/blood-2005-08-3123 · Cited by 42
Knoerzer, T. A., Nichols, D. E., Brewster, W. K., et al. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00041a025 · Cited by 41
Quinones, F. H., Haerens, M., & Christie, L. (2012) · Cited by 39
Retinal Tissue Oxygen Tension Imaging in the Rat
Shahidi, M., Wanek, J. M., Blair, N. P., Little, D. M., & Wu, T. T. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4710 · Cited by 38
Thompson, J. L., Rosell, D. R., Slifstein, M., Girgis, R. R., Xu, X., Ehrlich, Y., Kegeles, L. S., Hazlett, E. A., Abi‐Dargham, A., & Siever, L. J. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3566-6 · Cited by 38
“Full” dopamine D1 agonists in human caudate: Biochemical properties and therapeutic implications
Gilmore, J. H., Watts, V. J., Lawler, C. P., Noll, E., Nichols, D. E., & Mailman, R. B. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00014-w · Cited by 37
Assessment of the effects of AZD3480 on cognitive function in patients with schizophrenia
Velligan, D. I., Brenner, R., Sicuro, F., Walling, D. P., Riesenberg, R. A., Sfera, A., Merideth, C., Sweitzer, D. E., & Jaeger, J. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.10.004 · Cited by 36
Wilde, I., Lotz, S., Engelmann, D., Starke, A., van Zandbergen, G., Solbach, W., & Laskay, T. (2006) · Medical Microbiology and Immunology · doi:10.1007/s00430-006-0027-9 · Cited by 35
The safety of studies with intravenous Δ9-tetrahydrocannabinol in humans, with case histories
The Yale THC Study Group, Carbuto, M., Sewell, R. A., Williams, A. H., Forselius-Bielen, K., Braley, G., Elander, J., Pittman, B. P., Martin, A. M. S., Bhakta, S. G., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2417-y · Cited by 33
Isacson, R., Kull, B., Wahlestedt, C., & Salmi, P. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.11.016 · Cited by 31
Földy, C., Aradi, I., Howard, A. L., & Soltész, I. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.03096.x · Cited by 30
Neue Erkenntnisse zu Fumarsäureestern (Fumaderm®): Ergebnisse des 2. Experten‐Workshops
Mrowietz, U., Altmeyer, P. J., Augustin, M., et al. (2012) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0379.2012.08047.x · Cited by 29
Wright, W. S., McElhatten, R. M., & Harris, N. R. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.06.003 · Cited by 27
Morgan, N. H., Stanford, I. M., & Woodhall, G. L. (2008) · Neural Plasticity · doi:10.1155/2008/808564 · Cited by 27
Kasperkiewicz, M., Hirose, M., Recke, A., Schmidt, E., Zillikens, D., & Ludwig, R. J. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09680.x · Cited by 24
Slifstein, M., Suckow, R. F., Javitch, J. A., Cooper, T. B., Lieberman, J. A., & Abi‐Dargham, A. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.91 · Cited by 22
Crosson, L. A., Kroes, R. A., Moskal, J. R., & Linsenmeier, R. A. (2009) · PubMed Central · Cited by 22
Lei, G., Anastasio, N. C., Fu, Y., Neugebauer, V., & Johnson, K. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06030.x · Cited by 21
Enhancement of antibacterial superoxide-anion generation in human monocytes by fumaric acid esters
Zhu, K., & Mrowietz, U. (2005) · Archives of Dermatological Research · doi:10.1007/s00403-005-0598-0 · Cited by 20
Keimpema, E., Straiker, A. J., Mackie, K., Harkany, T., & Hjerling‐Leffler, J. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.224386 · Cited by 20
Berger, C., Berger, M., Anderson, D. J., & Riddell, S. R. (2010) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.2010.00451.x · Cited by 15
Self-citation
Cited by
Abramson, J. S., Palomba, M. L., Gordon, L. I., Lunning, M. A., Wang, M., Arnason, J., Mehta, A., Purev, E., Maloney, D. G., Andreadis, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31366-0 · Cited by 2,430
Self-citationCD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
Turtle, C. J., Hanafi, L.-A., Berger, C., Gooley, T. A., Cherian, S., Hudecek, M., Sommermeyer, D., Melville, K., Pender, B., Budiarto, T. M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85309 · Cited by 2,112
Self-citationTargeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Eyquem, J., Mansilla-Soto, J., Giavridis, T., van der Stegen, S. J. C., Hamieh, M., Cunanan, K. M., Odak, A., Gönen, M., & Sadelain, M. (2017) · Nature · doi:10.1038/nature21405 · Cited by 1,831
CAR T cells produced in vivo to treat cardiac injury
Rurik, J. G., Tombácz, I., Yadegari, A., Méndez Fernández, P. O., Shewale, S. V., Li, L., Kimura, T., Soliman, O. Y., Papp, T. E., Tam, Y. K., et al. (2022) · Science · doi:10.1126/science.abm0594 · Cited by 1,400
Long-term outcomes following CAR T cell therapy: what we know so far
Cappell, K. M., & Kochenderfer, J. N. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00754-1 · Cited by 1,382
Metadata
- Authors
- Sommermeyer, D., Hudecek, M., Kosasih, P. L., Gogishvili, T., Maloney, D. G., Turtle, C. J., & Riddell, S. R.
- Venue
- Leukemia
- Published
- 2015-09-15
- Volume
- 30
- Issue
- 2
- Pages
- 492-500
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2219506342
- Cited by
- 867
- References
- 265
- FWCI
- 21.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.